Induction of tetrasomy by human papillomavirus type 16 E7 protein is independent of pRb binding and disruption of differentiation by Southern, S A et al.
Induction of tetrasomy by human papillomavirus type 16 E7
protein is independent of pRb binding and disruption of
differentiation
SA Southern
1, MH Lewis
1 and CS Herrington*,1,2
1Department of Pathology, University of Liverpool, Duncan Building, Daulby Street, Liverpool L69 3GA, UK;
2Bute Medical School, University of
St Andrews, St Andrews KY16 9TS, UK
We have demonstrated previously that high-risk human papillomaviruses (HPVs) induce tetrasomy in low-grade squamous
intraepithelial lesions of the cervix. In this study we show that the E6 and E7 genes of high-risk HPV-16, but not those of low-risk
HPV-6, are independently able to induce tetrasomy when constitutively expressed in proliferating monolayer cultures of primary
human keratinocytes. Of seven HPV-16 E7 mutants analysed (H2P, D6–10, D21–24, C24G, S31G/S32G, A50S and S71I), five were
severely impaired in their ability to induce tetrasomy in monolayer and raft culture. Only mutant C24G induced tetrasomy to levels
comparable with wild-type E7 in monolayer and raft culture. This mutant shows strongly reduced binding to the retinoblastoma gene
product pRb. The casein kinase II phosphorylation defective mutant S31G/S32G induced tetrasomy to levels comparable with wild-
type E7 in raft culture, but not in monolayer culture, and induction of tetrasomy did not correlate with raft morphology. These results
indicate that pRb protein binding is not required for HPV-16 E7 associated tetrasomy and that tetrasomy is not directly related to the
ability of this protein to disrupt keratinocyte differentiation.
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Human Papillomaviruses (HPV) are small double-stranded DNA
viruses with a strict tropism for epithelial cells and 99.7% of
cervical cancers are associated with HPV infection (Walboomers
et al, 1999). Particular HPV types, most notably HPV 16 and 18,
predominate in this association and are thus referred to as high-
risk types. In previous studies we have shown that basal cell
tetrasomy occurs in low-grade squamous intraepithelial lesions of
the cervix (SILs) infected with high-risk HPVs but not in those
infected with low-risk HPVs (Southern et al, 1997). Tetrasomic
cells contain four separate copies of each chromosome instead of
two. In normal cells, replicated chromosomes remain as tightly
associated sister chromatid pairs until mitosis. Sister chromatid
separation is stringently regulated and only occurs after each
replicated chromosome has become aligned on the mitotic spindle.
In tetrasomic cells it would seem that the sister chromatids have
become separated but that a subsequent step in mitosis has
arrested or failed. Such failures in mitosis can lead to genetic
instability and are of cardinal importance in the cancer process.
HPVs encode two small proteins, E6 and E7 that act as potent
cell-cycle dysregulators and are able to drive infected cells into S-
phase to allow replication of viral DNA. In a productive HPV
infection the viral genome is maintained episomally and E6 and
E7 are expressed at low levels under viral cis- and trans-acting
control. During neoplastic progression the expression of E6 and E7
is de-repressed, usually as a result of integration of the viral DNA
into the host genome. Expression of high-risk E6 and E7 proteins
can immortalise primary human epithelial cells in vitro (Hawley-
Nelson et al, 1989) and both proteins bind to numerous cellular
target proteins (Kuhne and Banks, 1999; Zwerschke and Jansen-
Durr, 2000), several of which are also targets of adenovirus and
SV40 early proteins.
The best studied interaction of E7 is that with pRb (Helt and
Galloway, 2003). In vitro transformation assays of mutant and
chimeric E7 proteins from the archetypal high-risk type 16 and the
low-risk type 6 have shown that pRb binding affinity correlates
with transforming capacity (Heck et al, 1992). However, pRb-
binding is not sufficient for in vitro transformation by HPV-16 E7
(Banks et al, 1990). Studies on the interaction of E7 with pRb have
yielded the following model. In healthy cells, hypo-phosphorylated
pRb associates with the transcription factor E2F and prevents its
activation of transcription of many genes required for S-phase
progression (e.g. DNA polymerase a). As the cell progresses
through G1 pRb is sequentially phosphorylated at various sites by
cyclin-dependent kinases causing it to release E2F and permit
transcription of S-phase genes. Thus pRb, in its hypo-phosphory-
lated state, can act as a brake on cell-cycle progression and it must
be phosphorylated to allow the cell-cycle to continue to S-phase.
HPV-16 E7 protein binds to hypo-phosphorylated pRb preventing
its sequestration of E2F and potentiating its proteolytic degrada-
tion. This effectively removes one of the main nodes of cell-cycle
regulation at this point and facilitates unscheduled progression
into S-phase. This is potentiated by the direct binding of E7 to
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(Hwang et al, 2002). The role of pRb is not limited to the G1/S
boundary of the cell cycle. pRb deficient fibroblasts lose the ability
to sustain a G2 arrest in the presence of mitotic blocks and proceed
on into G1 and then S-phase without an intervening cell division
(Di Leonardo et al, 1997; Niculescu et al, 1998). Furthermore, pRb
functionally interacts, specifically during G2/M, with Hec1p, a
protein required for proper chromosome segregation (Zheng et al,
2000). The transcription factor E2F is also involved at G2/M. DNA
microarray analysis has shown that those genes transcriptionally
regulated by E2F fall into two classes; those expressed at G1/S and
another class expressed at G2/M (Ishida et al, 2001).
pRb is one member of a family of proteins that share a ‘pocket’
domain involved in protein/protein interactions. The three
members of the pocket-protein family, pRb, p107 and p130, seem
to have largely overlapping functions (Mulligan and Jacks, 1998).
While pRb is mutated or otherwise inactivated (e.g. by HPV E7) in
most human cancers, loss of function of p107 or p130 is rarely, if
ever, observed. p130 predominates in quiescent or terminally
differentiated cells and p107 predominates in proliferating cells.
Although E7 binds to all three proteins via the pocket domain it
preferentially binds p130 (Smith-McCune et al, 1999).
In a previous study we showed that tetrasomy occurs in
organotypic raft culture of primary human keratinocytes (PHKs)
expressing the (high-risk) HPV-18 E7 gene alone under control of
the native, differentiation dependent, HPV-18 enhancer/promoter
(Southern et al, 2001). Expression of HPV-18 E6 protein alone
under these conditions did not cause tetrasomy. However, the E6
and E7 proteins both disrupt G2/M checkpoints in vitro (Thomas
and Laimins, 1998). Hence, in the present study, we test the
hypothesis that the E6 and E7 proteins of high-risk HPV can
induce tetrasomy when expressed constitutively. We also test the
hypothesis that the induction of tetrasomy by E7 is a result of the
E7 protein’s interference with pRb function.
MATERIALS AND METHODS
Cell lines and culture
Primary human keratinocytes from neonatal foreskin (Clonetics)
were cultured in keratinocyte growth medium 2 (Clonetics).
Retroviral packaging cell lines were obtained from the American
Type Culture Collection (PA317 containing wild-type HPV genes;
Halbert et al, 1992) or given by Dr Denise Galloway (PG13 con-
taining mutant HPV-16 E7 genes; Demers et al, 1996) and were
cultured in Dulbecco’s modified Eagle’s medium with 10% foetal
calf serum.
Transduction and selection of PHKs
Fresh medium was applied to confluent cultures of packaging cells
and allowed to accumulate virus overnight. The medium was filtered
through 0.45mm cellulose acetate filters and combined with an equal
volume of keratinocyte growth medium 2 containing hexadimethr-
ine bromide (polybrene) (Sigma H9268) to a final concentration of
6mgml
 1. In total, 4ml of this mixture was applied to passage 1
monolayer PHKs at approximately 10% confluency in 25cm
2 flasks.
After 6h the medium was removed, the cells were rinsed in PBS
and fresh medium was added. Selection was begun 24h later with
G418 at 150mgml
 1 and continued for 48h. Mock-infected cultures
treated this way were dead by day 3 after selection.
Organotypic raft culture
A detailed protocol is described elsewhere (Wilson et al, 1992).
Briefly, 10
6 keratinocytes were seeded onto a collagen plug con-
taining 5 10
5 J2-3T3 feeder cells in one well of a six-well plate and
submerged in raft culture medium. When confluent the plug was
transferred onto a wire mesh grid in a 10cm Petri dish to raise it to
the air/liquid interface above raft culture medium. The cultures
were grown for 10 days then fixed in 10% neutral buffered
formalin for 2 days and embedded in paraffin wax. Raft culture
medium is 70% Dulbecco’s modified Eagle’s medium, 25% Ham’s
F12 medium, 5% foetal calf serum supplemented with 180mM
adenine, 5mgml
 1 insulin, 400ngml
 1 hydrocortisone, 5mgml
 1
transferrin, 200pM 3,30,5-triiodo-L-thyronine (Sigma T6397),
100pM cholera toxin, 5ngml
 1 epidermal growth factor,
2.5mgml
 1 fungizone (Life Technologies), 100Uml
 1 penicillin
G and 100mgml
 1 streptomycin.
PCR rescue and sequencing
Genomic DNA was prepared using a Qiagen blood/tissue-culture
small scale DNA isolation kit. LXSN vector specific flanking primers
were used in standard PCR conditions to amplify an approximately
400bp product, which was gel-purified and subjected to automated
sequencing of one strand. The results were unambiguous in each case.
Interphase cytogenetics
Monolayer cells were trypsinized, allowed to attach to glass slides
overnight in a droplet of medium in a CO2 incubator at 371C and
fixed by immersion in 10% neutral buffered formalin for 2 days.
Slides were previously treated with aminopropyltriethoxysilane
(Sigma A3648). 6mm sections of paraffin embedded raft cultures
were taken onto treated slides, heated overnight at 601C, dewaxed
in xylene and rehydrated through an ethanol series. The method of
hybridisation is described in detail elsewhere (Southern and
Herrington, 1996). Briefly, slides were pretreated with sodium
thiocyanate, pepsin/HCl and hybridized with biotin or digoxigenin
labelled alpha-satellite probes specific to either chromosome 1, 3
or 17. The chromosome 1 probe was kindly provided by Dr AH
Hopman (University of Limburg, Maastricht, the Netherlands) and
the chromosome 3 and 17 probes were purchased from Appligene/
Oncor. Signal was detected with peroxidase conjugated antibodies,
diaminobenzidine and hydrogen peroxide.
Scoring tetrasomy
Nuclei were classified at  630 magnification into five classes
depending on the number of spots present: 1, 2, 3, 4 and 5þ spots.
In monolayer culture the percentage tetrasomy is the number of 4-
spot nuclei divided by the total 100. In raft culture sections many
nuclei are truncated. We have shown previously that sectioned
material from a purely tetrasomic population produces a signal
distribution containing approximately equal numbers of nuclei
containing 3 and 4 spots (Southern and Herrington, 1996).
Therefore, the 3- and 4-spot classes were combined and classed
as tetrasomic. The P-values derived using w
2 comparisons were
multiplied by the number of comparisons, 6 in Figure 1 and 8 in
Figure 2 (a Bonferroni correction), to avoid type I errors (Altman,
1991). 95% confidence interval is  1.96SE to þ1.96SE.
RESULTS
The E6 and E7 genes of HPV type 16, but not those of type
6, are independently able to induce tetrasomy in primary
human keratinocyte monolayer culture
We investigated constitutive expression of both the E6 and E7
genes of the archetypal high-risk type 16, and also of the low-risk
type 6 HPV, by obtaining PA317 retrovirus packaging cell lines
generated in the laboratory of Dr Denise Galloway (Halbert et al,
1992), which contain the following genes inserted into the LXSN
retroviral vector: HPV16 E6 & E7, HPV6 E6 & E7 and LXSN
vector alone (ATCC, Manassas, VA, USA). In these constructs the
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the moloney murine leukaemia retroviral LTR. Primary human
keratinocytes growing as submerged monolayers were transduced
with retrovirus at passage 1, selected with G418 for 2 days and then
allowed to expand. The cultures were fixed and analysed at passage
3 (7 days after transduction for the HPV-16 constructs, 10–14 days
for the others). The cells were analysed by interphase cytogenetics
using biotinylated DNA probes specific for chromosomes 1, 3 and
17. We have previously shown that HPV-induced tetrasomy
involves at least chromosomes 1, 3, 4, 6, 10, 11, 17, 18 and X
(Giannoudis et al, 2000). The results are shown in Figure 1.
Significantly increased levels of tetrasomy occured in cultures
transduced with retroviruses expressing HPV16 E6 and E7 genes.
Those cultures transduced with retroviruses expressing HPV6 E6
or E7, as well as cultures transduced with LXSN vector, showed no
significant increase in levels of tetrasomy above uninfected PHKs.
Thus, the ability of these HPV proteins to induce tetrasomy
correlates with their ability to transform cells in vitro.
High affinity pRb binding is not required for induction of
tetrasomy by HPV16 E7
In order to map the domains of E7 required for its induction of
tetrasomy, we investigated seven HPV16 E7 mutants: H2P, D6–10,
D21–24, C24G, S31G/S32G, A50S and S71I. These mutants, the gift
of Dr Denise Galloway (Demers et al, 1996), were in the form of
LXSN constructs in PG13 retrovirus packaging cell lines. HPV-16
E7 protein has been notionally divided into domains based on
sequence homology to widely separated regions of the much larger
adenovirus E1a protein. Mutations H2P and D6–10 are located in
conserved region 1 (CR1), mutations D21–24, C24G and S31G/
S32G are located in CR2 and mutations A50S and S71I are located
close to the C-terminal metal-binding domain (Figure 2A). PHKs
were transduced at passage 1, selected for 2 days, expanded for 3–
4 days then split and grown in parallel as submerged monolayer
and organotypic raft cultures. Expression of the mutant proteins
under these conditions has been demonstrated previously (Demers
et al, 1996). Monolayer cultures were fixed at passage 3. Raft
cultures were grown for 10 days before fixation. After fixation the
presence of the correct mutant gene was confirmed in each case by
PCR rescue and sequencing. Tetrasomy was scored by interphase
cytogenetics using biotinylated DNA probes specific for chromo-
somes 1, 3 and 17. Only the C24G mutant E7 protein was able to
induce levels of tetrasomy similar to wild-type HPV16 E7 in
monolayer culture (Figure 2B). The other mutants all showed
strongly reduced levels of tetrasomy with least loss of effect being
shown by the C-terminal mutants A50S and S71I. In raft culture
the same pattern emerged with the exception that the S31G/S32G
protein gave a similar level of tetrasomy to wild type and C24G
(Figure 2C). The tetrasomy was predominantly suprabasal (data
not shown).
The ability of HPV16 E7 to induce tetrasomy is separable
from its ability to disrupt keratinocyte differentiation in
organotypic raft culture
Haematoxylin and eosin stained sections show three different
morphological groups in the organotypic raft cultures (Figure 3).
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Figure 1 Percentage tetrasomy induced in monolayer culture of PHKs
expressing of HPV-16 and HPV-6 E6 and E7 proteins. Indicated beneath
each bar is the number of nuclei counted (n) and the Bonferroni corrected
P-value (P) based on a w
2 test using two-way contingency tables compared
to uninfected. The error bars show the 95% confidence interval assuming a
normal distribution.
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Figure 2 Induction of tetrasomy by HPV-16 E7 mutant proteins. (A)
Schematic diagram of HPV-16 E7 protein showing sequence homology
with adenovirus E1a in the conserved regions CR1 and CR2. Positions of
mutations in CR1 and CR2 are underlined. The locations of pRb binding
and CKII phosphorylation sites are indicated. (B) Percentage tetrasomy
induced by mutant HPV-16 E7 proteins in monolayer culture of PHKs. (C)
Percentage tetrasomy induced by mutant HPV-16 E7 proteins in
organotypic raft culture of PHKs. Indicated beneath each bar is the number
of nuclei counted (n) and the Bonferroni corrected P-value (P) based on a
w
2 test using two-way contigency tables compared to LXSN. The error bars
show the 95% confidence interval assuming a normal distribution.
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mutant proteins A50S and S71I, a thick epithelium is formed
containing uniformly undifferentiated cells throughout. The
second group, represented by the mutant proteins H2P, D6–10,
D21–24 and C24G, as well as the LXSN vector, forms a very thin
epithelium containing differentiated cells. The third group,
represented only by mutant protein S31G/S32G, shows a thick
epithelium with distinct layers of basal (undifferentiated) and
spinous (differentiated) cells. Those E7 proteins inducing tetras-
omy in raft culture do not fall into any particular morphological
class. Induction of tetrasomy occurs in rafts from each class,
namely HPV-16 E7 wild type, C24G and S31G/S32G. Thus, the
ability of HPV-16 E7 mutant proteins to induce tetrasomy does not
correlate with any particular effect on keratinocyte differentiation
in raft culture.
DISCUSSION
In earlier studies we have shown that tetrasomy occurs in
a proportion of low-grade SILs infected with high-risk HPV
types but does not occur in SILs infected with low-risk HPV
types (Giannoudis et al, 2000). We also identified tetrasomy in
suprabasal keratinocytes in raft cultures expressing HPV 18 E7,
but not in rafts expressing E6, under transcriptional control of
the native HPV-18 enhancer/promoter (Southern et al, 2001).
However, the HPV-18 enhancer/promoter is strongly repressed in
basal cells and becomes derepressed when the cells migrate up the
epithelium and begin to differentiate. Hence, the ability of these
genes to induce tetrasomy in proliferating cells cannot be assessed.
Moreover, both E6 and E7 have been shown independently to
disrupt G2/M cell-cycle checkpoints in vitro (Thomas and Laimins,
1998). Therefore, in this study, we tested the hypothesis that
constitutive expression of both of these genes can induce
tetrasomy in proliferating cells. In monolayer culture, which most
closely approximates the basal/parabasal proliferating layer of an
epithelium, both E6 and E7 of HPV-16 were able to induce
tetrasomy. In contrast, the E6 and E7 genes of the low-risk
HPV type 6 were not able to induce tetrasomy. These findings
are consistent with the known biochemical properties of these
proteins.
To investigate further the induction of tetrasomy by HPV-16 E7
protein, we analysed monolayer and raft cultures of PHKs
transduced with retroviruses expressing mutant E7 proteins. These
seven are distributed throughout the protein and are well
characterised with respect to pRb-binding and transformation
(Demers et al, 1996). All but one of the mutants showed a
significant reduction in tetrasomy compared to wild-type E7 in
monolayer culture. This suggests that no single domain of the E7
protein is responsible for the effect and that induction of tetrasomy
is an indirect downstream effect of two or more E7 functions
residing in different parts of the protein.
Figure 3 (A) Haematoxylin and eosin stained sections of organotypic raft cultures of PHKs transduced with retrovirus expressing HPV-16 E7 mutant
proteins. Magnification  400. (B) Interphase cytogenetic staining of a raft culture section from each of the three morphological categories with a
chromosome 17 specific probe. Nuclei counterstained with haematoxylin. Magnification  630.
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tetrasomy was C24G. This substitution to glycine of the central
cysteine of the xLxCxE motif has been reported to abrogate
binding to pRb (Davies et al, 1993; Demers et al, 1996) and p130
(Smith-McCune et al, 1999), and to either reduce (Davies et al,
1993) or abrogate (Demers et al, 1996) binding to p107. This
suggests that pRb-binding is not required for induction of
tetrasomy. The related mutant D21–24, a deletion of xLxC from
the xLxCxE motif, is also unable to bind pRb or p107 (Davies et al,
1993; Phelps et al, 1992) but shows no induction of tetrasomy.
What is the functional difference between the C24G and the D21–
24 mutations? Both mutant proteins are unable to disrupt
keratinocyte differentiation (Demers et al, 1996 and see
Figure 3A), transactivate the adenovirus E2 promoter (Edmonds
and Vousden, 1989; Phelps et al, 1992) or transform cells in vitro
(Edmonds and Vousden, 1989; Phelps et al, 1992). However, the
C24G mutant protein is able to stimulate proliferation in
immortalized rodent fibroblasts (Caldeira et al, 2000). Further-
more, recent quantitative binding studies have shown that the
C24G mutant retains 30% of the pRb-binding affinity of the wild-
type E7 protein (apparent KDs of 14 and 4.5nM respectively) (Dong
et al, 2001). Nevertheless, this mutant, which exhibits 70%
reduction in pRb binding affinity, was able to induce a similar of
level of tetrasomy to wild-type protein. Thus, it can still be inferred
that induction of tetrasomy by E7 is not directly related to pRb-
binding. However, if C24G retains or accentuates some difference
in binding preference between the pocket proteins then the direct
involvement of p107 or p130 cannot be excluded. Alternatively, the
mechanism of induction of tetrasomy may be independent of
pocket-protein binding altogether. The D21–24 deletion mutant is
completely unable to bind to pRb and does not induce tetrasomy.
The difference between the findings for this mutant and those for
C24G may in part be related to a change (possibly conformational)
that impinges on some other E7 function additional to pocket-
protein binding that is not affected by C24G. The other mutants
analysed are able to bind to pRb but, with the exception of S31G/
S32G in raft culture, are unable to induce tetrasomy. Thus,
induction of tetrasomy does not segregate with pRb binding.
In organotypic raft culture C24G was joined by S31G/S32G in
possessing the ability to induce tetrasomy, which was predomi-
nantly suprabasal, to levels comparable with wild-type protein. The
two serines at positions 31 and 32 form part of the recognition site
for, and are phosphorylated by, casein kinase II. It is not clear why
the S31G/S32G mutant cannot induce tetrasomy in monolayer but
is capable of doing so in raft culture, but this differential ability is
compatible with our previous hypothesis that the mechanisms of
induction of basal and suprabasal tetrasomy are different (South-
ern et al, 2001). In monolayer culture the cells are undifferentiated
and cycling and most closely resemble the basal/parabasal layer of
an epithelium. Expression of E7 protein in these cells may disrupt
cell-cycle checkpoints, leading to tetrasomy, and our data suggest
that this property requires phosphorylation of the S31/S32 site. In
raft culture the keratinocytes form a squamous epithelium and the
E7 protein induces unscheduled DNA synthesis in a proportion of
postmitotic, differentiated keratinocytes (Cheng et al, 1995). Our
data suggest that phosphorylation at the S31/S32 site is not
required for this function. Only the S31G/S32G mutant gave a raft
morphology indicating both proliferation (a thickened raft) and
differentiation. Therefore, mutation of the CKII phosphorylation
site reduces the ability of the E7 protein to disrupt keratinocyte
differentiation but has no effect on induction of tetrasomy. Further
analysis of other mutations in the CR2 region of HPV-16 E7 may
clarify the mechanism.
The other rafts were either proliferative but relatively undiffer-
entiated (wild-type, A50S, S71I) or nonproliferative (vector, H2P,
D6–10, D21–24, C24G), in agreement with the findings of Demers
et al (1996). The induction of tetrasomy by C24G, S31G/S32G and
wild-type E7 demonstrates that this property is not related to the
ability of the E7 protein to disrupt keratinocyte differentiation. The
proportion of keratinocytes with detectable tetrasomy was
relatively low but this is compatible both with our previous study
(Southern et al, 2001) and with observations reported by others
(Chien et al, 2002). The latter study provided evidence that
postmitotic, differentiated keratinocytes expressing high-risk HPV
E7 protein have alternative fates, with only a minority undergoing
endoreduplication, consistent with our data.
The absence of tetrasomy in rafts expressing C-terminal mutants
A50S and S71I is consistent with the observation that, despite their
ability to bind to pRb, C-terminal mutations inhibit the ability of
E7 to induce S phase and endoreduplication in differentiated
keratinocytes and is compatible with the requirement for
inactivation of both pRb and p21 by HPV 16 E7 in order to
bypass cell-cycle arrest (Helt et al, 2002). The requirement for
factors additional to abrogation of the p16INK4A/pRb checkpoint
for induction of centrosome abnormalities during keratinocyte
immortalisation supports the involvement of additional E7
functions (Piboonniyom et al, 2003). Thus, centrosome abnorm-
alities were demonstrable in keratinocytes immortalised by a
combination of HPV 16 E7 and hTERT but not in those
immortalised by cdk4/hTERT or by hTERT alone, the latter
having lost expression of p16INK4A.
In summary, both the E6 and E7 proteins of HPV 16 can induce
tetrasomy in proliferating keratinocytes. Mutational analysis of the
E7 protein shows that the ability of E7 to induce tetrasomy is
separable from both pRb binding and disruption of keratinocyte
differentiation, indicating that this phenomenon is not directly
related to either of these properties and is likely to require multiple
functions of the E7 protein.
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